Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-22-024069
Filing Date
2022-06-23
Accepted
2022-06-23 16:09:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1255762
2 EX-FILING FEES xene-exfilingfees_10.htm EX-FILING FEES 60400
3 GRAPHIC gnxu4ppxcq1a000003.jpg GRAPHIC 10276
4 GRAPHIC gnxu4ppxcq1a000002.jpg GRAPHIC 7563
5 GRAPHIC gnxu4ppxcq1a000001.jpg GRAPHIC 10276
  Complete submission text file 0001564590-22-024069.txt   1356305
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260010 | Film No.: 221035520
SIC: 2834 Pharmaceutical Preparations